
Adicet Bio, Inc. — Investor Relations & Filings
Adicet Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies. The company's core mission is to create 'off-the-shelf' treatments for patients with cancer and autoimmune diseases. By engineering gamma delta T cells, Adicet aims to provide readily available and potent immunotherapies. Its proprietary platform is designed to leverage the unique characteristics of these cells, which possess both innate and adaptive immune properties, to develop potentially first-in-class and best-in-class therapeutic candidates that can effectively target and eliminate diseased cells.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A | 2026-05-20 | English | |
| 10-Q - Adicet Bio, Inc. (0001720580) (Filer) | 2026-05-13 | English | |
| 8-K - Adicet Bio, Inc. (0001720580) (Filer) | 2026-05-13 | English | |
| 8-K - Adicet Bio, Inc. (0001720580) (Filer) | 2026-04-28 | English | |
| EFFECT - Adicet Bio, Inc. (0001720580) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 46691773 | 10-K/A | 2026-05-20 | English | ||
| 45765351 | 10-Q - Adicet Bio, Inc. (0001720580) (Filer) | 2026-05-13 | English | ||
| 45762074 | 8-K - Adicet Bio, Inc. (0001720580) (Filer) | 2026-05-13 | English | ||
| 38155653 | 8-K - Adicet Bio, Inc. (0001720580) (Filer) | 2026-04-28 | English | ||
| 33023626 | EFFECT - Adicet Bio, Inc. (0001720580) (Filer) | 2026-03-24 | English | ||
| 31460051 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31460041 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31459993 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32897243 | 4 - ADICET BIO, INC. (0001720580) (Filer) | 2026-01-27 | English | ||
| 32897244 | 4 - ADICET BIO, INC. (0001720580) (Filer) | 2026-01-27 | English | ||
| 31459999 | 4 Filing | 2026-01-27 | English | ||
| 31459894 | 4 Filing | 2026-01-27 | English | ||
| 13068636 | 8-K | 2026-01-07 | English | ||
|
2025
2 filings
| |||||
| 13068638 | 8-K | 2025-12-29 | English | ||
| 13068637 | 8-K | 2025-12-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
Atrium Therapeutics, Inc.
Pioneering precision RNA medicines for cardiac diseases, fo…
|
RNA | US | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
Adicet Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34412/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34412 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34412 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34412 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34412}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Adicet Bio, Inc. (id: 34412)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.